These findings suggested that IDO and IL-6 play important role in cancer progress and chemotherapy efficacy which maybe predictable markers for the chemotherapy response to aid clinical decision-making of more effective therapies for breast cancer. This evidence concerns the gene IL6 and breast carcinoma.